| Medical and Health Sciences | Lifetime | 709 | US 367 | 99.97 |
| Economics and Finance | Lifetime | 796 | US 447 | 99.49 |
| General Health Professions | Lifetime | 157 | US 79 | 99.80 |
| Nephrology | Lifetime | 37 | US 23 | 99.71 |
| Econometrics and Quantitative Economics | Lifetime | 487 | US 289 | 99.52 |
| Public, Environmental and Occupational Health | Lifetime | 632 | US 323 | 99.12 |
| Emergency Medical Services | Lifetime | 276 | US 140 | 97.40 |
| Transplantation | Lifetime | 319 | US 144 | 89.13 |
| Obstetrics and Gynecology | Lifetime | 970 | US 424 | 80.43 |
| General Health Professions | 2021-2025 | 321 | US 117 | 97.59 |
| Nephrology | 2021-2025 | 98 | US 39 | 96.36 |
| Econometrics and Quantitative Economics | 2021-2025 | 815 | US 224 | 94.79 |
| Genetics | 2021-2025 | 522 | US 195 | 85.21 |
| Dialysis and Renal Disease Management | Lifetime | 25 | US 13 | 99.80 |
| Healthcare Policy and Management | Lifetime | 28 | US 21 | 99.60 |
| Chronic Kidney Disease and Diabetes | Lifetime | 42 | US 22 | 99.65 |
| Healthcare cost, quality, practices | Lifetime | 24 | US 14 | 99.20 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 142 | US 70 | 99.50 |
| Organ Donation and Transplantation | Lifetime | 79 | US 52 | 99.16 |
| Central Venous Catheters and Hemodialysis | Lifetime | 164 | US 66 | 98.66 |
| Chronic Disease Management Strategies | Lifetime | 218 | US 83 | 98.31 |
| Global Health Workforce Issues | Lifetime | 127 | US 53 | 97.68 |
| Blood Pressure and Hypertension Studies | Lifetime | 428 | US 187 | 98.74 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 503 | US 267 | 98.06 |
| Patient-Provider Communication in Healthcare | Lifetime | 217 | US 94 | 97.59 |
| Primary Care and Health Outcomes | Lifetime | 419 | US 245 | 97.68 |
| Diversity and Career in Medicine | Lifetime | 240 | US 181 | 96.22 |
| Patient Satisfaction in Healthcare | Lifetime | 259 | US 163 | 97.16 |
| Pharmaceutical Economics and Policy | Lifetime | 337 | US 165 | 95.75 |
| Erythropoietin and Anemia Treatment | Lifetime | 278 | US 113 | 95.83 |
| Ethics in Clinical Research | Lifetime | 370 | US 209 | 94.52 |
| Global Health Care Issues | Lifetime | 807 | US 333 | 95.02 |
| Acute Kidney Injury Research | Lifetime | 542 | US 216 | 95.05 |
| Neurological and metabolic disorders | Lifetime | 639 | US 258 | 90.16 |
| Pharmaceutical industry and healthcare | Lifetime | 450 | US 272 | 87.89 |
| Blood donation and transfusion practices | Lifetime | 719 | US 289 | 87.45 |
| Race, Genetics, and Society | Lifetime | 367 | US 171 | 77.99 |
| Cultural Competency in Health Care | Lifetime | 609 | US 290 | 78.09 |
| Interpreting and Communication in Healthcare | Lifetime | 929 | US 285 | 77.33 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 111 | US 39 | 96.88 |
| Race, Genetics, and Society | 2021-2025 | 5 | US 4 | 91.34 |
| Dialysis and Renal Disease Management | 2021-2025 | 194 | US 39 | 95.98 |
| Healthcare Policy and Management | 2021-2025 | 228 | US 179 | 93.12 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 944 | US 431 | 86.88 |
| Ethics in Clinical Research | 2021-2025 | 435 | US 188 | 82.80 |
| Renal and Vascular Pathologies | 2021-2025 | 700 | US 180 | 79.18 |